ScholarIQanswers from OpenAlex
Amylin Pharmaceuticals
FunderResearch funding and supported work
Amylin Pharmaceuticals is a funder indexed in ScholarIQ from OpenAlex.
What is known about Amylin Pharmaceuticals?
ScholarIQrecord summary
biopharmaceutical company, acquired by AstraZeneca in 2007
How many works does Amylin Pharmaceuticals have?
ScholarIQindexed works
Amylin Pharmaceuticals has 667 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Amylin Pharmaceuticals?
ScholarIQopenalex
The OpenAlex for Amylin Pharmaceuticals is on the source record.
What is the ROR of Amylin Pharmaceuticals?
ScholarIQror
The ROR for Amylin Pharmaceuticals is on the source record.
What are the most-cited papers on Amylin Pharmaceuticals?
ScholarIQmost cited works
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
William C. Duckworth, Carlos Abraira, Thomas Moritz, Domenic J. Reda, Nicholas Emanuele, Peter D. Reaven, Franklin J. Zieve, Jennifer A. Marks, Stephen N. Davis, Rodney A. Hayward, Stuart Warren, Steven Goldman, Madeline McCarren, Mary Ellen Vitek, William G. Henderson, Grant D. Huang
Effect of once‐weekly exenatide on estimated glomerular filtration rate slope depends on baseline renal risk: A <i>post hoc</i> analysis of the <scp>EXSCEL</scp> trial
Annemarie B. van der Aart‐van der Beek, Lindsay E. Clegg, Robert C. Penland, David W. Boulton, C. David Sjöström, Robert J. Mentz, Rury R. Holman, Hiddo J.L. Heerspink